EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Evolution of the Trial Master File Process
Editorial Archive

Evolution of the Trial Master File Process

There are a number of challenges facing the pharmaceutical industry, such as improving the quality of TMF documentation through a compliant centralised filing system....
10 April 2014 Editorial Archive | Regulatory V5 I6 | Volume 5 Issue 6
Continue Reading →
Cardiovascular Therapeutics Watch Page
Editorial Archive

Cardiovascular Therapeutics Watch Page

Drug-resistant hypertension (RHTN) is a 'hot topic' in hypertension literature. Uncontrolled RHTN is defined as blood pressure (BP) above goal on an appropriate pharm...
10 April 2014 Editorial Archive | Volume 5 Issue 6 | Watch Pages V5 I6
Continue Reading →
Aortic Stiffness and Chronic Obstructive Pulmonary Disease
Editorial Archive

Aortic Stiffness and Chronic Obstructive Pulmonary Disease

Arterial stiffness, especially stiffness in the large elastic arteries such as the aorta, is now widely-recognised as an important factor in the development and progr...
10 April 2014 Editorial Archive | Volume 5 Issue 6 | Watch Pages V5 I6
Continue Reading →
How Changes in Practice are Changing Bleeding End Points in Coronary Interventional Trials
Editorial Archive

How Changes in Practice are Changing Bleeding End Points in Coronary Interventional Trials

Cardiac catheterisation and coronary intervention both require catheters to be placed into arteries - engendering risk. In their paper, L. Allen Kindman, Joshua Betch...
7 April 2014 Editorial Archive | Special Features V6 I2 | Volume 6 Issue 2
Continue Reading →
Orphan Drugs: R&D Challenges with Updates from Turkey and Middle East Countries
Editorial Archive

Orphan Drugs: R&D Challenges with Updates from Turkey and Middle East Countries

Rare diseases (RDs) are an important public-health issue and a challenge for the medical community. They are called ‘health orphans’, as a result of being neglected f...
7 April 2014 Editorial Archive | Special Features V6 I2 | Volume 6 Issue 2
Continue Reading →
Import of Investigational Medicinal Products into Israel
Editorial Archive

Import of Investigational Medicinal Products into Israel

Israel has a robust and growing pharmaceutical industry, particularly for biopharmaceuticals and advanced therapeutic medicinal products (ATMP). It is home to one of ...
7 April 2014 Editorial Archive | It & Logistics V6 I2 | Volume 6 Issue 2
Continue Reading →
The Role of Mobile Technology in Reshaping the Pharmaceutical Industry
Editorial Archive

The Role of Mobile Technology in Reshaping the Pharmaceutical Industry

With the growth of mobile devices, healthcare professionals (HCPs) and the general public are accessing and collecting medical information via their smartphones. This...
7 April 2014 Editorial Archive | It & Logistics V6 I2 | Volume 6 Issue 2
Continue Reading →
CNS Clinical Trials in Russia
Editorial Archive

CNS Clinical Trials in Russia

In Russia, most CNS clinical studies have been conducted in MS, epilepsy, AD, stroke, depression and schizophrenia. A number of leading Russian biopharmaceutical comp...
7 April 2014 Editorial Archive | Therapeutics V6 I2 | Volume 6 Issue 2
Continue Reading →
New Standards in Alzheimer’s Disease Trial Design
Editorial Archive

New Standards in Alzheimer’s Disease Trial Design

Over the last decade, the only new treatment for Alzheimer’s to make it to market is memantine (Namenda™).  The number of failed drug programs in that span provides a...
7 April 2014 Editorial Archive | Therapeutics V6 I2 | Volume 6 Issue 2
Continue Reading →
Patient-derived Xenograft (PDX) Model: An Evolution in Oncology Drug Study
Editorial Archive

Patient-derived Xenograft (PDX) Model: An Evolution in Oncology Drug Study

In order to address shortcomings at the discovery stage in oncology studies, PDX has recently emerged as the upcoming technique. Through the PDX model, original tumou...
7 April 2014 Editorial Archive | Therapeutics V6 I2 | Volume 6 Issue 2
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte